IIPLA News
Sunday, August 2, 2026

ELEKTROS Explores Licensing Options for U.S. Patent Amid Expanding Lithium and EV Charging Initiatives

The company reinforces its strategic focus on Sierra Leone lithium projects and advanced EV charging technologies while assessing patent portfolio monetization

IIPLA News Deskanonymous access0 articles left this week
ELEKTROS Explores Licensing Options for U.S. Patent Amid Expanding Lithium and EV Charging Initiatives

ELEKTROS Inc. (OTC PINK: ELEK) announced on August 2, 2026, that it is advancing its long-term vision centered on hard-rock lithium opportunities in Sierra Leone, critical minerals, and electric vehicle (EV) charging innovations. The company highlighted its U.S. Patent No. 12,522,100 B1 as a key intellectual property asset underpinning its EV charging technology initiatives.

Headquartered in West Palm Beach, Florida, ELEKTROS is actively evaluating strategic alternatives for its patent portfolio, including potential licensing discussions. The company stressed its commitment to protecting its intellectual property rights while pursuing disciplined business development.

The announcement comes amid sustained strength in the electrification sector, with growing investor interest in battery materials, critical minerals, and next-generation technologies. ELEKTROS believes that increased awareness of its lithium strategy and patent holdings has broadened its appeal among retail, microcap, and institutional investors.

Chief Executive Officer Shlomo Bleier remarked, "We believe the current valuation encourages investors to conduct their own independent due diligence. In our opinion, purchasing shares at an attractive entry point can resemble owning options that never expire, allowing long-term shareholders to participate in our vision. That is our opinion, not a guarantee, and every investment decision should be made carefully."

ELEKTROS’s lithium strategy focuses on hard-rock deposits in Sierra Leone, a region with significant potential for critical mineral extraction essential to battery production and electric mobility.

The company’s patent portfolio, anchored by U.S. Patent No. 12,522,100 B1, relates to advanced EV charging technology, positioning ELEKTROS to capitalize on the global transition toward electric mobility, battery storage, and charging infrastructure.

ELEKTROS is exploring licensing opportunities and other strategic alternatives to monetize its intellectual property while maintaining rigorous protection of its rights.

The company’s public filings and patent details are accessible for investor review, with the patent available at https://patents.google.com/patent/US12522100B1/en.

ELEKTROS cautioned that forward-looking statements contained in its release are subject to risks and uncertainties that could cause actual results to differ materially. The company undertakes no obligation to update these statements except as required by law.

For further information, ELEKTROS can be contacted via phone at 786-477-9003 or email at elektrosinc@gmail.com. Additional corporate details are available on its website at www.elektros.energy.

As the global market for lithium and EV charging technologies continues to expand, ELEKTROS’s strategic initiatives and intellectual property portfolio position it to participate in long-term growth opportunities within the electrification and critical minerals sectors.

Share This Article
Ready-to-post copy includes the article link.

ELEKTROS Explores Licensing Options for U.S. Patent Amid Expanding Lithium and EV Charging Initiatives ELEKTROS Inc. (OTC PINK: ELEK) has reaffirmed its long-term strategic commitment to hard-rock lithium development in Sierra Leone and innovation in electric vehicle charging technology, anchored by U.S. Patent No. 12,52... Read the full IIPLA article: https://iipla.org/news/elektros-explores-licensing-options-for-u-s-patent-amid-expanding-lithium-and-ev-charging-initiatives

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026